Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in pharmaceutical

Glenmark Pharma Gets Tentative Nod From USFDA For Anticoagulant Drug

Quoting IQVIA sales data for the 12 month period ending August 2020, Glenmark said Pradaxa capsules, 75, 110 mg and 150 mg, market achieved annual sales of approximately USD 550.9 million.

Read More

Insurers, Drugmakers Sail Into Unknown With COVID Vaccine Rollout

Pharmaceutical companies normally manage the risks of transporting their products through buying insurance or relying on an in-house insurer, known as a "captive" insurer.

Read More

Is There A Vaccine For COVID-19?

Researchers and Scientists started dealing with candidate vaccines to secure against SARS-CoV-2 in January after the infection's hereditary code, or genome had been interpreted.

Read More

Agri, Pharma Exports Grows During COVID-19 Pandemic: Commerce Secy

India's exports dipped 8.74 per cent on a yearly basis in November to USD 23.52 billion on account of contraction in shipments of key sectors like petroleum, engineering, chemicals and gems and jewellery.

Read More

Driving An Owner-Driven Business

Piramal has the industry advantage to score high on sustainability amongst companies in India as its pharmaceutical business that contributed 41 per cent to the company’s business contributes to saving lives by the nature of its products and services.

Read More

Sanofi Renews Deal With WHO To Fight Tropical Diseases, Sleeping Sickness

Sanofi said its new five-year commitment with the WHO would see Sanofi provide financial support of $5 million per year over those five years, to finance research and work dedicated to tackling those ailments.

Read More

Gilead To Acquire German Biotech Firm MYR For About 1.15 Billion Euros

The German company expects to submit an application for the accelerated approval of Hepcludex, which works by blocking viral entry into liver cells, in the United States in the second half of 2021.

Read More

US AstraZeneca Vaccine Trial Will Clear Confusion On How Well It Works - US Scientist

AstraZeneca Plc is one of the leading vaccine developers, but interim data released Nov. 23 from trials in Britain and Brazil showed a vastly divergent performance when the vaccine was tested in two different dose combinations.

Read More

Sinovac Secures $515 Million To Boost COVID-19 Vaccine Production

Brazil's Butantan Institute biomedical centre, which is running a Phase 3 trial of CoronaVac in the country, said last week that Sinovac was expected to publish efficacy results from its vaccine trials by Dec. 15.

Read More

Mexico Set To Sign Pfizer Vaccine Deal On Wednesday

Pfizer has submitted the details about its vaccine to Mexico's health regulator, Cofepris, and the country's foreign minister last month said the government expects the vaccine to reach Mexico in December.

Read More

AstraZeneca Sells Cholesterol Drug Rights To Grünenthal For $320 Million

AstraZeneca will continue to manufacture and supply the drug to Grünenthal during a transition period and will continue to sell it in other regions, including North America and China

Read More

India Regulators Probe Alleged AstraZeneca Shot Reaction, Trial Continues

A 40-year-old man said in a complaint seen by Reuters that he had suffered serious "neurological and psychological" symptoms after receiving the vaccine in a trial being run by the British drugmaker's partner Serum Institute of India (SII).

Read More

AstraZeneca CEO Expects To Run New Global Trial Of COVID-19 Vaccine

Instead of adding the trial to an ongoing U.S. process, AstraZeneca might launch a fresh study to evaluate a lower dosage of its vaccine that performed better than a full dosage, Pascal Soriot told Bloomberg News.

Read More

Philippines, Private Firms To Sign Vaccine Supply Deal With AstraZeneca

The private firms will pay for the vaccine and donate half of the supply to the government, with the other half to be used to cover employees in the private sector, Concepcion said, without identifying the private companies.

Read More

OxyContin Maker Purdue Pharma Pleads Guilty To Criminal Charges

Purdue's plea deal carries more than $5.5 billion in penalties, most of which will go unpaid. A $3.54 billion criminal fine is set to be considered alongside trillions of dollars in unsecured claims as part of Purdue's bankruptcy proceedings.

Read More